Advertisement

Topics

The Binding Site Group Company Profile

04:02 EDT 25th September 2017 | BioPortfolio


News Articles [1330 Associated News Articles listed on BioPortfolio]

New Recombinant Parvovirus Antigens Now Available from Binding Site

Binding Site’s Immunologicals Group is pleased to announce the addition of eight new recombinant antigens to its broad offering of products for in-vitro diagnostic (IVD) manufacturing and resear...

Binding Site launches new antigens and antibodies for infectious/contagious diseases

The Immunologicals Group of The Binding Site is pleased to announce the launch of a number of new monoclonal antibodies and recombinant antigens focused on a variety of infectious/contagious disease s...

Discovery of a cryptic peptide-binding site on PCSK9 and design of antagonists

PCSK9 binds to and promotes degradation of LDLR, thus regulating serum levels of LDL. An accessible groove in PCSK9, adjacent to the LDLR-binding site, can be targeted by peptides that disrupt the LDL...

Model This?

Via Ash Jogalekar on Twitter, I came across this new paper from researchers at AstraZeneca (and collaborators in Sweden, the UK, and Denmark) on the synthesis and activity of some plasmin inhibitors....

De novo design of a hyperstable non-natural protein–ligand complex with sub-Å accuracy

The first demonstration of a protein designed entirely from first principles that binds a small-molecule cofactor in a precisely predetermined orientation has now been described. The design method uti...

Development of nanosensor capable of detecting herbicide and its target enzyme binding

(World Scientific) Livia F. Rodrigues and the Nanoneurobiophysics research group from the Federal University of São Carlos, Sorocaba, SP, Brazil, have published their studies on nanomechanical sensin...

2017 Iron Unsaturated Binding Capacity Test Volume and Sales Forecasts: US, Europe, JapanHospitals, Commercial Labs, POC Locations [Updated: 30032017] Prices from USD $750

This new report from VPGMarketResearch provides analysis of Iron Unsaturated Binding Capacity testing, including clinical significance, current and emerging diagnostic procedures, as well as test volu...

2017 Iron Unsaturated Binding Capacity Test Volume and Sales Forecasts: US, Europe, JapanHospitals, Commercial Labs, POC Locations [Updated: 22032017] Prices from USD $750

This new report from VPGMarketResearch provides analysis of Iron Unsaturated Binding Capacity testing, including clinical significance, current and emerging diagnostic procedures, as well as test volu...

PubMed Articles [6372 Associated PubMed Articles listed on BioPortfolio]

Acetyl group coordinated progression through the catalytic cycle of an arylalkylamine N-acetyltransferase.

The transfer of an acetyl group from acetyl-CoA to an acceptor amine is a ubiquitous biochemical transformation catalyzed by Gcn5-related N-acetyltransferases (GNATs). Although it is established that ...

Discovery of a cryptic peptide-binding site on PCSK9 and design of antagonists.

Proprotein convertase subtilisin/kexin type 9 (PCSK9) regulates plasma LDL cholesterol (LDL-c) levels by promoting the degradation of liver LDL receptors (LDLRs). Antibodies that inhibit PCSK9 binding...

Dihedral angle preferences of DNA and RNA binding amino acid residues in proteins.

A protein can interact with DNA or RNA molecules to perform various cellular processes. Identifying or analyzing DNA/RNA binding site amino acid residues is important to understand molecular recogniti...

Clinical characteristics, risk factors, and outcomes of usual and unusual site venous thromboembolism.

: The primary objective was to demonstrate the different risk factors among patients presenting with usual and unusual site venous thromboembolism (VTE). The secondary objectives were to compare clini...

Quantitative specificity of STAT1 and several variants.

The quantitative specificity of the STAT1 transcription factor was determined by measuring the relative affinity to hundreds of variants of the consensus binding site including variations in the lengt...

Clinical Trials [4763 Associated Clinical Trials listed on BioPortfolio]

Identification of Donors of CD36-Deficient Platelets Among Japanese Individuals on the NIH Campus

Plasma histidine-rich glycoprotein (HRG) binds to platelets in the presence of zinc (1). This binding is totally blocked by a monoclonal antibody directed against platelet membrane CD36. ...

First-in-Human Positron Emission Tomography Study Using the 18F-αvβ6-Binding-Peptide

This clinical trial studies the side effects of 18F-alphavbeta6-binding-peptide and how well it works in imaging patients with primary or cancer that has spread to the breast, colorectal, ...

Ultrasound for Neuraxial Anesthesia

The patients will be allocated to 2 groups: the ultrasound group and the palpation group. Ultrasound detection of the puncture site will be performed to the patients of the one group (grou...

Study of the Role of Soluble Inhibitor of Interleukin 22, Interleukin 22 Binding Protein (IL-22BP), in Chronic Inflammatory Bowel Disease

IL-22 is an IL-10 family cytokine that plays major actions to increase intestinal epithelial barrier function and regeneration during experimental colitis. IL-22 binding protein is a small...

Method of Exit Site Care in Chronic Peritoneal Dialysis Patients

Peritoneal dialysis accounts for more than 70% of the dialysis modality in Hong Kong. Exit site infection (ESI) is one of the causes leading to peritoneal catheter removal. Appropriate exi...

Companies [2553 Associated Companies listed on BioPortfolio]

Binding Site

Binding Site is committed to improving patient lives worldwide through education, collaboration and innovation. The company focuses on research, development, manufacture and distr...

The Binding Site Group

Carsen Group Inc

Carsen Group is a diverse company, offering innovative products in a wide range of applications to our customers in the Health Care, Research, and Industrial markets. A wholly owned subsidiary of Cant...

EURAPHARMA

The EURAPHARMA Group takes every effort to the extent of its capabilities to ensure that the information made available on this site is both correct, the content of which it reserves the right to corr...

Healthy Heart Programme

Welcome to www.heartpro.co.uk. This site is owned by McNeil Ltd. A Johnson & Johnson Company. This Privacy Policy tells you how we collect, use, and disclose personally identifiable information that y...

More Information about "The Binding Site Group" on BioPortfolio

We have published hundreds of The Binding Site Group news stories on BioPortfolio along with dozens of The Binding Site Group Clinical Trials and PubMed Articles about The Binding Site Group for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of The Binding Site Group Companies in our database. You can also find out about relevant The Binding Site Group Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record